Charles Schwab’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.04M | Buy |
128,243
+12,328
| +11% | +$90.3K | ﹤0.01% | 2997 |
|
|
2026
Q1 | $741K | Sell |
115,915
-9,457
| -8% | -$61K | ﹤0.01% | 2991 |
|
|
2025
Q4 | $746K | Hold |
125,372
| – | – | ﹤0.01% | 3021 |
|
|
2025
Q3 | $666K | Sell |
125,372
-2,071
| -2% | -$8.78K | ﹤0.01% | 3077 |
|
|
2025
Q2 | $437K | Buy |
127,443
+9,189
| +8% | +$29.3K | ﹤0.01% | 3181 |
|
|
2025
Q1 | $350K | Buy |
118,254
+588
| +0.5% | +$1.84K | ﹤0.01% | 3168 |
|
|
2024
Q4 | $359K | Hold |
117,666
| – | – | ﹤0.01% | 3236 |
|
|
2024
Q3 | $300K | Sell |
117,666
-8,574
| -7% | -$26K | ﹤0.01% | 3283 |
|
|
2024
Q2 | $412K | Buy |
126,240
+106,787
| +549% | +$469K | ﹤0.01% | 3273 |
|
|
2024
Q1 | $103K | Hold |
19,453
| – | – | ﹤0.01% | 3304 |
|
|
2023
Q4 | $84.2K | Hold |
19,453
| – | – | ﹤0.01% | 3359 |
|
|
2023
Q3 | $51.2K | Hold |
19,453
| – | – | ﹤0.01% | 3406 |
|
|
2023
Q2 | $68.7K | Hold |
19,453
| – | – | ﹤0.01% | 3380 |
|
|
2023
Q1 | $60.1K | Hold |
19,453
| – | – | ﹤0.01% | 3322 |
|
|
2022
Q4 | $82.3K | Buy |
+19,453
| New | +$67.1K | ﹤0.01% | 3286 |
|
|
2022
Q3 | – | Sell |
-28,820
| Closed | -$83K | – | 3539 |
|
|
2022
Q2 | $83K | Sell |
28,820
-46,174
| -62% | -$115K | ﹤0.01% | 3304 |
|
|
2022
Q1 | $216K | Sell |
74,994
-5,658
| -7% | -$14.6K | ﹤0.01% | 3294 |
|
|
2021
Q4 | $246K | Hold |
80,652
| – | – | ﹤0.01% | 3328 |
|
|
2021
Q3 | $566K | Sell |
80,652
-199,023
| -71% | -$1.49M | ﹤0.01% | 3104 |
|
|
2021
Q2 | $2.57M | Buy |
279,675
+11,719
| +4% | +$119K | ﹤0.01% | 2626 |
|
|
2021
Q1 | $2.6M | Sell |
267,956
-60,020
| -18% | -$670K | ﹤0.01% | 2588 |
|
|
2020
Q4 | $3.37M | Buy |
327,976
+5,731
| +2% | +$58K | ﹤0.01% | 2410 |
|
|
2020
Q3 | $3.25M | Sell |
322,245
-252
| -0.1% | -$2.57K | ﹤0.01% | 2291 |
|
|
2020
Q2 | $3.36M | Buy |
322,497
+12,735
| +4% | +$132K | ﹤0.01% | 2212 |
|
|
2020
Q1 | $2.62M | Sell |
309,762
-28,027
| -8% | -$272K | ﹤0.01% | 2157 |
|
|
2019
Q4 | $2.96M | Sell |
337,789
-11,049
| -3% | -$91.5K | ﹤0.01% | 2284 |
|
|
2019
Q3 | $3.76M | Buy |
348,838
+167,331
| +92% | +$1.81M | ﹤0.01% | 2121 |
|
|
2019
Q2 | $2.31M | Buy |
181,507
+7,216
| +4% | +$166K | ﹤0.01% | 2323 |
|
|
2019
Q1 | $6.76M | Buy |
174,291
+12,580
| +8% | +$384K | ﹤0.01% | 1826 |
|
|
2018
Q4 | $3.29M | Sell |
161,711
-1,833
| -1% | -$55K | ﹤0.01% | 2126 |
|
|
2018
Q3 | $7.5M | Buy |
163,544
+3,150
| +2% | +$152K | 0.01% | 1817 |
|
|
2018
Q2 | $9.49M | Buy |
160,394
+9,813
| +7% | +$569K | 0.01% | 1638 |
|
|
2018
Q1 | $10.2M | Buy |
150,581
+10,383
| +7% | +$777K | 0.01% | 1474 |
|
|
2017
Q4 | $13.9M | Buy |
140,198
+5,031
| +4% | +$563K | 0.01% | 1258 |
|
|
2017
Q3 | $16.2M | Buy |
135,167
+11,787
| +10% | +$1.1M | 0.01% | 1080 |
|
|
2017
Q2 | $10.8M | Buy |
123,380
+4,068
| +3% | +$228K | 0.01% | 1301 |
|
|
2017
Q1 | $4.44M | Buy |
119,312
+6,138
| +5% | +$224K | ﹤0.01% | 1826 |
|
|
2016
Q4 | $3.48M | Buy |
113,174
+21,655
| +24% | +$936K | ﹤0.01% | 1932 |
|
|
2016
Q3 | $6.14M | Sell |
91,519
-13,503
| -13% | -$683K | 0.01% | 1512 |
|
|
2016
Q2 | $3.13M | Buy |
105,022
+46,522
| +80% | +$1.45M | ﹤0.01% | 1847 |
|
|
2016
Q1 | $1.72M | Sell |
58,500
-4,542
| -7% | -$205K | ﹤0.01% | 2129 |
|
|
2015
Q4 | $4.94M | Buy |
63,042
+4,157
| +7% | +$326K | 0.01% | 1527 |
|
|
2015
Q3 | $4.44M | Buy |
58,885
+27,579
| +88% | +$2.61M | 0.01% | 1553 |
|
|
2015
Q2 | $3.65M | Sell |
31,306
-39,732
| -56% | -$7.2M | 0.01% | 1752 |
|
|
2015
Q1 | $16.8M | Buy |
71,038
+5,024
| +8% | +$1.07M | 0.02% | 648 |
|
|
2014
Q4 | $12.5M | Buy |
66,014
+1,337
| +2% | +$297K | 0.02% | 749 |
|
|
2014
Q3 | $15.4M | Sell |
64,677
-867
| -1% | -$178K | 0.03% | 583 |
|
|
2014
Q2 | $4.33M | Buy |
65,544
+2,298
| +4% | +$163K | 0.01% | 1521 |
|
|
2014
Q1 | $6.59M | Buy |
63,246
+6,897
| +12% | +$811K | 0.01% | 1105 |
|
|
2013
Q4 | $5.83M | Buy |
56,349
+2,013
| +4% | +$118K | 0.01% | 1133 |
|
|
2013
Q3 | $3.03M | Buy |
54,336
+13,717
| +34% | +$739K | 0.01% | 1571 |
|
|
2013
Q2 | $1.93M | Buy |
+40,619
| New | +$1.43M | ﹤0.01% | 1782 |
|
Other funds holding PBYI
ACA
Charles Schwab's PBYI Position: Q2 2026 in Review
Charles Schwab increased its Puma Biotechnology (PBYI) stake by 11% in Q2 2026, buying an estimated $90.3K and bringing the position to 128,243 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2997.
Charles Schwab first reported a position in PBYI in Q2 2013 and has held it in 52 quarters since. The position peaked at $16.8M in Q1 2015. 161 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.
- Charles Schwab held 128,243 shares of Puma Biotechnology worth $1.04M as of Q2 2026.
- Charles Schwab bought 12,328 Puma Biotechnology shares in Q2 2026, an estimated $90.3K.
- Puma Biotechnology made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2997 holding.
- Charles Schwab first reported a position in Puma Biotechnology in Q2 2013 and has held it in 52 quarters since.
- Charles Schwab's Puma Biotechnology position peaked at $16.8M in Q1 2015.
- 161 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.